SGLT2 Inhibitors Tied to Uptick in Hemoglobin and Hematocrit

(MedPage Today) -- DENVER -- Treatment with SGLT2 inhibitors was linked with modest but statistically significant increases in hemoglobin and hematocrit levels across a broad spectrum of patient populations, according to a systematic review and...